相关实验视频

Updated: May 10, 2026

Generation of Cationic Nanoliposomes for the Efficient Delivery of In Vitro Transcribed Messenger RNA

Generation of Cationic Nanoliposomes for the Efficient Delivery of In Vitro Transcribed Messenger RNA

Published on: February 1, 2019

多个尾部电离性脂质可以改善体内mRNA传递效率,并具有生物安全性

Chao Liu¹, Yuhao Jiang¹, Wenliang Xue¹

¹School of Chemistry and Chemical Engineering, Southeast University, Nanjing 211189, China.

International journal of pharmaceutics

|October 25, 2024

概括

研究人员开发了用于mRNA输送的新型电离性脂质纳米粒子 (LNP). 具有四个疏水尾巴的脂质表现出更高的传递效率和长时间的表达,为LNP发展提供了新的策略.

科学领域:

生物技术是生物技术.
材料科学材料科学材料科学
药物运输药物运输药物运输

背景情况:

电离性脂质纳米颗粒 (LNP) 对于mRNA输送至关重要.
电离性脂质的疏水尾部会影响LNP的形成和mRNA的释放.

研究的目的:

调查疏水尾部特征 (数量,链条长度,双键) 对LNP交付效率的影响.
为了合成和表征基于伊米达的新型电离性脂质.

主要方法:

具有变化的疏水尾巴的电离性脂质的合成和表征.
使用微流体混合制备LNP,并进行颗粒大小分析 (100-150nm,PDI<0.2).
在体内测试 (溶酶体逃逸,细胞转移,细胞毒性) 和体内研究 (免疫性,毒性,mRNA表达持续时间,肝外输送).

主要成果:

具有四个疏水尾巴的电离性脂质显示出卓越的mRNA递送效率.
特定的脂质 (U-15,U-17,U-18,U-19) 显示出最高的性能.
U-19显示长时间的mRNA表达和特定的肝外输送.
所有测试的脂质都没有显著的体内毒性或免疫性.

结论:

疏水尾数是设计有效的可离子化脂质用于mRNA输送的关键因素.
基于伊米达的四尾电离性脂质代表了先进的LNP开发的有希望的策略.
这项研究为优化LNP配方以提高治疗疗效提供了宝贵的见解.

关键词:

电离性脂质是可以电离的.脂质纳米颗粒是一种纳米粒子.多个尾巴多个尾巴.尾巴对称的对称性尾巴对称性提供mRNA的交付.

更多相关视频

Using Lipid Nanoparticles for the Delivery of Chemically Modified mRNA into Mammalian Cells

Using Lipid Nanoparticles for the Delivery of Chemically Modified mRNA into Mammalian Cells

Published on: June 10, 2022

Testing the In Vitro and In Vivo Efficiency of mRNA-Lipid Nanoparticles Formulated by Microfluidic Mixing

Testing the In Vitro and In Vivo Efficiency of mRNA-Lipid Nanoparticles Formulated by Microfluidic Mixing

Published on: January 20, 2023

相关概念视频

Bioavailability Enhancement: Drug Permeability Enhancement

Bioavailability Enhancement: Drug Permeability Enhancement

After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt secretion,...

Modified-Release Drug Delivery Systems: Bioavailability

Modified-Release Drug Delivery Systems: Bioavailability

Modified-release (MR) dosage forms are designed to extend drug release over time, thereby maintaining stable plasma concentrations and reducing dosing frequency. However, their bioavailability is typically below 100% due to incomplete drug release and presystemic metabolism, and limitations in drug permeability across the gastrointestinal epithelium, all of which can restrict the fraction of the drug reaching systemic circulation. Consequently, studying the in vivo bioavailability of MR...